It's precisely that paragraph that didn't compute with me. The company has borne that so-called "administrative burden" for YEARS without wimpering about it. Why get all bothered about it on November 2nd, when the PPS is only 15 cents or so less than the 200 day support level? They HAD to know that that paragraph was going to send the PPS plummeting ... and immediately.
Some have speculated that BD may be a suitor. Perhaps. But if you're ATRN, and being courted by BD, do you want to be $1.90 or $0.125?
Something is missing.
Some have speculated that BD may be a suitor. Perhaps. But if you're ATRN, and being courted by BD, do you want to be $1.90 or $0.125?
Something is missing.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
